These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10849575)

  • 1. Effects of hyperglycaemia and hyperinsulinaemia on plasma amino acid levels in obese subjects with normal glucose tolerance.
    Marchesini G; Bianchi G; Rossi B; Muggeo M; Bonora E
    Int J Obes Relat Metab Disord; 2000 May; 24(5):552-8. PubMed ID: 10849575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man.
    Del Prato S; Leonetti F; Simonson DC; Sheehan P; Matsuda M; DeFronzo RA
    Diabetologia; 1994 Oct; 37(10):1025-35. PubMed ID: 7851681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinaemia, obesity, and syndrome X.
    Zavaroni I; Bonini L; Fantuzzi M; Dall'Aglio E; Passeri M; Reaven GM
    J Intern Med; 1994 Jan; 235(1):51-6. PubMed ID: 8283160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose and insulin suppression of plasma free fatty acids in obese subjects with normal glucose tolerance or mild, newly diagnosed type 2 (non-insulin-dependent) diabetes.
    Zancanaro C; Cigolini M; Bonora E; Moghetti P; Querena M; Muggeo M
    J Endocrinol Invest; 1990 Jan; 13(1):55-9. PubMed ID: 1969430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired suppression of plasma free fatty acids and triglycerides by acute hyperglycaemia-induced hyperinsulinaemia and alterations in high density lipoproteins in essential hypertension.
    Ligtenberg JJ; Van Tol A; Van Haeften TW; Sluiter WJ; Reitsma WD; Dullaart RP
    J Intern Med; 1996 Oct; 240(4):233-42. PubMed ID: 8918515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma free fatty acid concentration during hyperglycemic glucose clamp with and without somatostatin infusion in obese subjects with normal glucose tolerance.
    Zancanaro C; Cigolini M; Bonora E; Moghetti P; Cacciatori V; Querena M; Muggeo M
    Int J Obes; 1990 Jul; 14(7):551-7. PubMed ID: 1977721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children.
    Caprio S; Bronson M; Sherwin RS; Rife F; Tamborlane WV
    Diabetologia; 1996 Dec; 39(12):1489-97. PubMed ID: 8960831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
    Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
    Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance.
    Ratzmann KP; Besch W; Witt S; Schulz B
    Diabetologia; 1981 Sep; 21(3):192-7. PubMed ID: 6117492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mild-to-moderate hyperglycaemia per se on glucose production and uptake in the elderly.
    Paolisso G; Marrazzo G; de Riu S; Sgambato S; Varricchio M; d'Onofrio F; Lefèbvre P
    Eur J Med; 1992 Apr; 1(1):6-12. PubMed ID: 1341981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of hyperinsulinaemia in apparently healthy non-obese young adults: role of insulin secretion, clearance and action and associations with plasma amino acids.
    Hamley S; Kloosterman D; Duthie T; Dalla Man C; Visentin R; Mason SA; Ang T; Selathurai A; Kaur G; Morales-Scholz MG; Howlett KF; Kowalski GM; Shaw CS; Bruce CR
    Diabetologia; 2019 Dec; 62(12):2310-2324. PubMed ID: 31489455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus.
    Oomen PH; van Tol A; Hattori H; Smit AJ; Scheek LM; Dullaart RP
    Diabet Med; 2005 Jun; 22(6):768-74. PubMed ID: 15910630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity worsens cardiovascular risk profiles independently of hyperinsulinaemia.
    Bonora E; Targher G; Zenere MB; Saggiani F; Alberiche MP; Branzi P; Muggeo M
    J Intern Med; 1997 Jun; 241(6):463-70. PubMed ID: 10497621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women.
    Kamath V; Jones CN; Yip JC; Varasteh BB; Cincotta AH; Reaven GM; Chen YD
    Diabetes Care; 1997 Nov; 20(11):1697-701. PubMed ID: 9353611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate depletion has profound effects on the muscle amino acid and glucose metabolism during hyperinsulinaemia.
    Ebeling P; Tuominen JA; Laipio ML; Virtanen MA; Koivisto E; Koivisto VA
    Diabetes Obes Metab; 2001 Apr; 3(2):113-20. PubMed ID: 11298734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
    Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A
    Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinaemia in hypertensive subjects: validity of a test for the detection of insulin resistance in clinical practice.
    Vanhala MJ; Pitkäjärvi TK; Keinänen-Kiukaanniemi SM; Kumpusalo EA; Takala JK
    J Hum Hypertens; 1998 Jul; 12(7):463-7. PubMed ID: 9702932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of hyperglycaemia on fed jejunal motility: potential role of hyperinsulinaemia.
    Byrne MM; Pluntke K; Wank U; Schirra J; Arnold R; Göke B; Katschinski M
    Eur J Clin Invest; 1998 Jan; 28(1):72-8. PubMed ID: 9502190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of increased plasma non-esterified fatty acids (NEFAs) on arginine-stimulated insulin secretion in obese humans.
    Carpentier A; Giacca A; Lewis GF
    Diabetologia; 2001 Nov; 44(11):1989-97. PubMed ID: 11719829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes.
    Blüher M; Unger R; Rassoul F; Richter V; Paschke R
    Diabetologia; 2002 Feb; 45(2):210-6. PubMed ID: 11935152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.